Pharmacogenetics of warfarin and healthcare costs - real-world data analysis.

The difference in the costs of bleeding-related hospitalization between genetically sensitive and normal warfarin responders may justify genotype-guided warfarin dosing. Further studies with larger sample sizes would be needed to verify the result. This article is protected by copyright. All rights reserved.